甲流疫苗审批生产“三同步” 特审速度与国际接轨,保障质量任重道远

The Emergency Approval of H1N1 Flu Vaccines Launched in China

甲流以肆虐全球之势在蔓延,虽不如"非典"般人人自危,但疫苗生产上市也成为全国关注焦点。SFDA对甲流疫苗生产的部署体现出颇具国际水平的快速、科学与成熟。部署虽精彩,但要做到过程与结果俱完美仍有不少细节需要注意。

H1N1 flu cases have been reported in many countries around the world, and approval of H1N1 flu vaccines attracts attentions nationwide. The emergency approval has been initiated by SFDA, it will be a long way to the successful launching of H1N1 flu vaccines in China.